Bryan Supran

Bryan Supran appears in our data through filings on Alnylam Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 1 October 2025 and 2 October 2026, the trades on record add up to 3 filings.

Every open-market trade on record is a sale: 1 sale worth €355k. The rest of the record consists of 2 share grants. 2026 to date brings no purchases and 1 sale.

The latest filing, published on 6 October 2026, reports an open-market sale of €355k in Alnylam Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.